Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Jobtailor is seeking a Senior Statistical Scientist to lead statistical input for HTA submissions across Europe, supporting EU JCA evidence generation and local adaptations. The role requires strong leadership in cross‑functional teams, advanced statistical methods, and collaboration
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Responsibilities Close collaboration with cross-functional teams to support the quantitative needs for HTA submissions in Europe Provide strategic statistical input into evidence generation activities and analyses required for the EU JCA Provide quantitative support for local HTA